Outcomes among Veterans with T2D at Time of Departure from Virtual Clinic: A Nationwide, Real World Study

被引：0
|
作者：
Fell, Brandon
Vantieghem, Michelle
Mckenzie, Amy L.
Ratner, Robert E.
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-1245-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1245-P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Real-World Evaluation of the Association between Cardiovascular Outcomes and T2D Therapy
    Thiel, Ellen
    Marder, William D.
    Cefalu, William T.
    Darsow, Tamara
    Petersen, Matt
    Latts, Lisa
    DIABETES, 2018, 67
  • [2] Activation, Physical Activity, and Outcomes Among Individuals With T2D
    Nair, Radhika
    Meadows, Eric
    Sheer, Richard
    Lipkovich, Ilya
    Poon, Jiat-Ling
    Zhao, Zhenxiang
    Benneyworth, Brian
    Pasquale, Margaret
    AMERICAN JOURNAL OF MANAGED CARE, 2022, 28 (08): : 374 - +
  • [3] Real-World Effectiveness among Patients with Type 2 Diabetes (T2D) Initiating Tirzepatide (TZP)
    Mody, Reema
    Desai, Karishma
    Teng, Chia-Chen
    Reznor, Gally
    Stockbower, Grace
    Grabner, Michael
    Benneyworth, Brian D.
    DIABETES, 2024, 73
  • [4] DISCOVER-A Global Study Program to Assess Real-World Evidence on Treatment and Outcomes of Patients with Type 2 Diabetes (T2D)
    Ji, Linong
    Charbonnel, Bernard
    Cook, William
    Fenici, Peter
    Garcia-Sanchez, Ricardo
    Gomes, Marilia B.
    Hammar, Niklas
    Hashigami, Kiyoshi
    Khunti, Kamlesh
    Nicolucci, Antonio
    Shestakova, Marina V.
    Shimomura, Iichiro
    Surmont, Filip Ame
    Medina, Jesus
    DIABETES, 2015, 64 : A692 - A692
  • [5] Real-World Effectiveness of Tirzepatide among People with Obesity or Overweight without Type 2 Diabetes (T2D)
    Hankosky, Emily R.
    Desai, Karishma
    Chinthammit, Chanadda
    Grabner, Michael
    Stockbower, Grace
    He, Xuanyao
    Mojdami, Donna
    Wenziger, Cachet
    Gibble, Theresa Hunter
    DIABETES, 2024, 73
  • [6] REAL WORLD INCIDENCE OF TYPE 2 DIABETES (T2D) COMPLICATIONS LEADING TO HOSPITALIZATION IN FRANCE: THE RECODE STUDY
    Bouee, S.
    Cochinaire, A.
    Godard, C.
    Sabater, F. J.
    Amelineau, E.
    Emery, C.
    Cotte, F. E.
    VALUE IN HEALTH, 2013, 16 (07) : A434 - A434
  • [7] Outcomes among Patients with Type 2 Diabetes (T2D) Receiving Basal Insulin with Mealtime Insulin or Exenatide BID: A Retrospective Study Using Real-World EMR Data
    Lang, Kathleen
    Nguyen, Hiep
    Huang, Huan
    Kaufman, Elise
    Levin, Philip
    DIABETES, 2015, 64 : A428 - A428
  • [8] REAL-WORLD ECONOMIC OUTCOMES AMONG PATIENTS WITH TYPE 2 DIABETES (T2D) TREATED WITH DULAGLUTIDE (DU) VS. BASAL INSULIN (BI) IN THE US: THE DISPEL™ STUDY
    Mody, R.
    Huang, Q.
    Yu, M.
    Zhang, X.
    Wang, L.
    Grabner, M.
    Patel, H.
    VALUE IN HEALTH, 2019, 22 : S149 - S150
  • [9] Postmarketing Real-World Effectiveness of Hydroxychloroquine (HCQ) in Treatment of Patients with T2D
    Pareek, Anil
    Dharmadhikari, Shruti
    Mehta, Ravi T.
    Naidu, Kumar B.
    DIABETES, 2020, 69
  • [10] Prevalence of CVD and Evaluation of Standard of Care in T2D: A Nationwide Study in Primary Care
    Rungby, Jorgen
    Schou, Morten
    Warrer, Per
    Ytte, Lars
    Andersen, Gert S.
    DIABETES, 2017, 66 : A650 - A650
12345